1. Home
  2. OCEA vs DEVS Comparison

OCEA vs DEVS Comparison

Compare OCEA & DEVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCEA
  • DEVS
  • Stock Information
  • Founded
  • OCEA 2019
  • DEVS N/A
  • Country
  • OCEA United States
  • DEVS Canada
  • Employees
  • OCEA N/A
  • DEVS N/A
  • Industry
  • OCEA Biotechnology: Pharmaceutical Preparations
  • DEVS
  • Sector
  • OCEA Health Care
  • DEVS
  • Exchange
  • OCEA Nasdaq
  • DEVS NYSE
  • Market Cap
  • OCEA 20.5M
  • DEVS 16.5M
  • IPO Year
  • OCEA N/A
  • DEVS N/A
  • Fundamental
  • Price
  • OCEA $0.54
  • DEVS $0.66
  • Analyst Decision
  • OCEA
  • DEVS
  • Analyst Count
  • OCEA 0
  • DEVS 0
  • Target Price
  • OCEA N/A
  • DEVS N/A
  • AVG Volume (30 Days)
  • OCEA 617.7K
  • DEVS 2.4M
  • Earning Date
  • OCEA 01-13-2025
  • DEVS 02-12-2025
  • Dividend Yield
  • OCEA N/A
  • DEVS N/A
  • EPS Growth
  • OCEA N/A
  • DEVS N/A
  • EPS
  • OCEA N/A
  • DEVS N/A
  • Revenue
  • OCEA N/A
  • DEVS N/A
  • Revenue This Year
  • OCEA N/A
  • DEVS N/A
  • Revenue Next Year
  • OCEA N/A
  • DEVS N/A
  • P/E Ratio
  • OCEA N/A
  • DEVS N/A
  • Revenue Growth
  • OCEA N/A
  • DEVS N/A
  • 52 Week Low
  • OCEA $0.46
  • DEVS $0.48
  • 52 Week High
  • OCEA $7.79
  • DEVS $1.91
  • Technical
  • Relative Strength Index (RSI)
  • OCEA 40.01
  • DEVS N/A
  • Support Level
  • OCEA $0.53
  • DEVS N/A
  • Resistance Level
  • OCEA $0.70
  • DEVS N/A
  • Average True Range (ATR)
  • OCEA 0.08
  • DEVS 0.00
  • MACD
  • OCEA -0.00
  • DEVS 0.00
  • Stochastic Oscillator
  • OCEA 4.31
  • DEVS 0.00

About OCEA Ocean Biomedical Inc.

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

About DEVS DEVVSTREAM CORP

DevvStream Corp is a technology based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve their sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.

Share on Social Networks: